Patient Guide: A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 184 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05002569
Status: TERMINATED
Condition: Melanoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 184 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Springdale, Arkansas
  • Los Angeles, California
  • • And 181 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily